Stockscreener 앱 받기
6.29
1.62%
0.10
시간 외 거래:
6.17
-0.12
-1.91%
전일 마감가:
$6.19
열려 있는:
$6.21
하루 거래량:
1.13M
Relative Volume:
0.65
시가총액:
$487.57M
수익:
$14.79M
순이익/손실:
$-102.44M
주가수익비율:
-2.0691
EPS:
-3.04
순현금흐름:
$-91.73M
1주 성능:
-7.91%
1개월 성능:
+20.04%
6개월 성능:
+118.40%
1년 성능:
-15.57%
1일 변동 폭
$6.20
$6.53
1주일 범위
$6.09
$7.0407
52주 변동 폭
$2.41
$10.37
솔리드 바이오 Stock (SLDB) Company Profile
명칭
Solid Biosciences Inc
전화
617-337-4680
주소
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
SLDB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLDB
Solid Biosciences Inc
|
6.29 | 504.63M | 14.79M | -102.44M | -91.73M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
솔리드 바이오 Stock (SLDB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-26 | 개시 | Citigroup | Buy |
| 2025-01-08 | 개시 | Truist | Buy |
| 2024-12-13 | 개시 | Wedbush | Outperform |
| 2024-12-10 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-06-24 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | 재개 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | William Blair | Outperform |
| 2024-03-15 | 개시 | Citigroup | Buy |
| 2024-03-14 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | 개시 | H.C. Wainwright | Buy |
| 2021-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-05-27 | 개시 | Jefferies | Buy |
| 2021-03-16 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-11 | 개시 | Evercore ISI | Outperform |
| 2019-08-29 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2019-08-19 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-02-08 | 업그레이드 | Citigroup | Sell → Neutral |
| 2019-02-08 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | 개시 | Citigroup | Sell |
| 2018-09-06 | 개시 | Credit Suisse | Neutral |
모두보기
솔리드 바이오 주식(SLDB)의 최신 뉴스
Wyckoff Accumulation Phase Possible in Solid Biosciences Inc.Breakout Momentum Picks With Protection Outlined - beatles.ru
Solid Biosciences SLDB 2025Q2 Earnings Preview Upside Potential on Strategic Developments - AInvest
Solid Biosciences Inc expected to post a loss of 50 cents a shareEarnings Preview - TradingView
Solid Biosciences Inc. shares rise 1.03% after-hours following Wall Street's recovery from jobs report-fueled losses. - AInvest
A Quick Look at Today's Ratings for Solid Biosciences(SLDB.US), With a Forecast Between $10 to $20 - 富途牛牛
What is the dividend policy of Solid Biosciences Inc. stockGet timely alerts on market opportunities - Jammu Links News
Should I hold or sell Solid Biosciences Inc. stock in 2025Discover stocks with massive upside potential - Jammu Links News
How strong is Solid Biosciences Inc. company’s balance sheetGet daily expert analysis for smarter investing - Jammu Links News
What are the latest earnings results for Solid Biosciences Inc.Robust investment performance - Jammu Links News
Is Solid Biosciences Inc. stock overvalued or undervaluedAchieve rapid returns with smart investment plans - Jammu Links News
What catalysts could drive Solid Biosciences Inc. stock higher in 2025Track top-performing stocks effortlessly - Jammu Links News
What drives Solid Biosciences Inc. stock priceConsistent double returns - Jammu Links News
Solid Biosciences Inc. Stock Analysis and ForecastIdentify undervalued stocks poised to rally - Jammu Links News
What makes Solid Biosciences Inc. stock price move sharplyBuild a diversified portfolio for risk management - Jammu Links News
What are Solid Biosciences Inc. company’s key revenue driversMaximize returns with data-driven strategies - Jammu Links News
When is Solid Biosciences Inc. stock expected to show significant growthDiscover undervalued stocks before they soar - Jammu Links News
What institutional investors are buying Solid Biosciences Inc. stockAchieve superior capital gains with smart trades - Jammu Links News
Solid Biosciences shares fall 2.78% after-hours following inducement grants announcement. - AInvest
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Solid Biosciences Strengthens Team with 55,450 RSU Grants for Key Genetic Medicine Experts - Stock Titan
Institutional Tools Highlight Unusual Flow in Solid Biosciences Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
What institutions are buying Solid Biosciences Inc. stock nowEarnings Play Trade Plan With Alerts Shared - metal.it
Technical Charts Suggest Momentum Shift in Solid Biosciences Inc.Oversold Recovery Opportunity Stocks Attract Buyers - metal.it
Solid Biosciences’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com
Solid Biosciences Inc. Approaches Support With Recovery in SightEntry Alert Based on Volume Spikes Detected - metal.it
Momentum Traders Eye Solid Biosciences Inc. for Quick BounceROI Boosting Trade Opportunity Calendar Published - metal.it
Why Solid Biosciences Inc. stock attracts strong analyst attention2x Return Forecast - metal.it
How volatile is Solid Biosciences Inc. stock compared to the marketMarket-leading profit generation - jammulinksnews.com
Will Solid Biosciences Inc. stock benefit from interest rate changesFree Predictions - metal.it
J.P. Morgan Keeps Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail
J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $15 - 富途牛牛
Is Solid Biosciences Inc. a good long term investmentUnstoppable profit momentum - PrintWeekIndia
What analysts say about Solid Biosciences Inc. stockFree Popular Stock Recommendations - PrintWeekIndia
솔리드 바이오 (SLDB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):